183 related articles for article (PubMed ID: 11023918)
21. Production of bispecific and trispecific F(ab)2 and F(ab)3 antibody derivatives.
French RR
Methods Mol Biol; 1998; 80():121-34. PubMed ID: 9664369
[No Abstract] [Full Text] [Related]
22. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
Boehm MK; Woof JM; Kerr MA; Perkins SJ
J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
[TBL] [Abstract][Full Text] [Related]
23. Middle Level IM-MS and CIU Experiments for Improved Therapeutic Immunoglobulin Subclass Fingerprinting.
Botzanowski T; Hernandez-Alba O; Malissard M; Wagner-Rousset E; Deslignière E; Colas O; Haeuw JF; Beck A; Cianférani S
Anal Chem; 2020 Jul; 92(13):8827-8835. PubMed ID: 32453570
[TBL] [Abstract][Full Text] [Related]
24. Mouse IgG2b monoclonal antibody fragmentation. Preparation and purification of Fab, Fc and Fab/c fragments.
Demignot S; Garnett MC; Baldwin RW
J Immunol Methods; 1989 Jul; 121(2):209-17. PubMed ID: 2503561
[TBL] [Abstract][Full Text] [Related]
25. Purification of antibody fragments via interaction with detergent micellar aggregates.
Dhandapani G; Wachtel E; Das I; Sheves M; Patchornik G
Sci Rep; 2021 Jun; 11(1):11697. PubMed ID: 34083598
[TBL] [Abstract][Full Text] [Related]
26. Improved procedure for preparation of F(ab')2 fragments of mouse IgGs by papain digestion.
Boguslawski SJ; Ledden DJ; Fredrickson RA
J Immunol Methods; 1989 Jun; 120(1):51-6. PubMed ID: 2732475
[TBL] [Abstract][Full Text] [Related]
27. Perturbation of thermal unfolding and aggregation of human IgG1 Fc fragment by Hofmeister anions.
Zhang-van Enk J; Mason BD; Yu L; Zhang L; Hamouda W; Huang G; Liu D; Remmele RL; Zhang J
Mol Pharm; 2013 Feb; 10(2):619-30. PubMed ID: 23256580
[TBL] [Abstract][Full Text] [Related]
28. Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry.
Ghirlando R; Lund J; Goodall M; Jefferis R
Immunol Lett; 1999 May; 68(1):47-52. PubMed ID: 10397155
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies.
Spiridon CI; Guinn S; Vitetta ES
Clin Cancer Res; 2004 May; 10(10):3542-51. PubMed ID: 15161714
[TBL] [Abstract][Full Text] [Related]
30. High-Pressure, Low-Temperature Induced Unfolding and Aggregation of Monoclonal Antibodies: Role of the Fc and Fab Fragments.
Berger JE; Teixeira SCM; Reed K; Razinkov VI; Sloey CJ; Qi W; Roberts CJ
J Phys Chem B; 2022 Jun; 126(24):4431-4441. PubMed ID: 35675067
[TBL] [Abstract][Full Text] [Related]
31. [Interaction between CH2 and CH3-domains of human immunoglobulin G1 in glycosylated and aglycosylated Fc-fragments].
Tishchenko VM
Biofizika; 1999; 44(5):811-2. PubMed ID: 10624519
[TBL] [Abstract][Full Text] [Related]
32. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.
Ionescu RM; Vlasak J; Price C; Kirchmeier M
J Pharm Sci; 2008 Apr; 97(4):1414-26. PubMed ID: 17721938
[TBL] [Abstract][Full Text] [Related]
33. Scanning force microscopy and fluorescence microscopy of microcontact printed antibodies and antibody fragments.
LaGraff JR; Chu-LaGraff Q
Langmuir; 2006 May; 22(10):4685-93. PubMed ID: 16649783
[TBL] [Abstract][Full Text] [Related]
34. Exploring variation in binding of Protein A and Protein G to immunoglobulin type G by isothermal titration calorimetry.
Lund LN; Christensen T; Toone E; Houen G; Staby A; St Hilaire PM
J Mol Recognit; 2011; 24(6):945-52. PubMed ID: 22038801
[TBL] [Abstract][Full Text] [Related]
35. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
36. Measurement of protein interaction bioenergetics: application to structural variants of anti-sCD4 antibody.
Doyle ML; Brigham-Burke M; Blackburn MN; Brooks IS; Smith TM; Newman R; Reff M; Stafford WF; Sweet RW; Truneh A; Hensley P; O'Shannessy DJ
Methods Enzymol; 2000; 323():207-30. PubMed ID: 10944754
[TBL] [Abstract][Full Text] [Related]
37. A 'molten globule'-like unfolding intermediate of a four domain protein, the Fc fragment of the IgG molecule.
Vonderviszt F; Lakatos S; Gál P; Sárvári M; Závodszky P
Biochem Biophys Res Commun; 1987 Oct; 148(1):92-8. PubMed ID: 3675596
[TBL] [Abstract][Full Text] [Related]
38. Improved method for pepsinolysis of mouse IgG(1) molecules to F(ab')(2) fragments.
Wilson DS; Wu J; Peluso P; Nock S
J Immunol Methods; 2002 Feb; 260(1-2):29-36. PubMed ID: 11792373
[TBL] [Abstract][Full Text] [Related]
39. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
Al-Abdulla I; Casewell NR; Landon J
J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
[TBL] [Abstract][Full Text] [Related]
40. Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain.
Raju TS; Scallon BJ
Biochem Biophys Res Commun; 2006 Mar; 341(3):797-803. PubMed ID: 16442075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
